Clinical Trial Update: Temozolomide in Treating Young Patients With Refractory or Recurrent Leukemia [Phase 1]

View source ↗

Summary

Phase 1 trial of temozolomide in pediatric patients with refractory or recurrent leukemia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• Temodar (Temozolomide)

Snippet

Sponsor: Children's Oncology Group | Conditions: Leukemia | Phase 1 | Status: COMPLETED